Dinaciclib (SCH 727965)
Catalog No. A11129
Dinaciclib (SCH 727965)是一种有效且选择性的细胞周期蛋白依赖性激酶(CDK)抑制剂,选择性抑制CDK1,CDK2,CDK5和CDK9,IC50值分别为3、1、1和4 nM。
- Sepideh Izadi, .et al. Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression, Pharm Res, 2020, Sep 17;37(10):196 PMID: 32944844
- Shahin Hallaj, .et al. Inhibition of CD73 using folate targeted nanoparticles carrying anti-CD73 siRNA potentiates anticancer efficacy of Dinaciclib, Life Sci, 2020, Jul 26 PMID: 32726663
- Washio I, .et al. Impact of Breast Cancer Resistance Protein Expression on the In Vitro Efficacy of Anticancer Drugs in Pancreatic Cancer Cell Lines, Drug Metab Dispos, 2018, Mar;46(3):214-222 PMID: 29246888
Catalog Num | A11129 |
---|---|
M. Wt | 396.5 |
Formula | C21H28N6O2 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 779353-01-4 |
Synonyms | SCH727965, SCH-727965 |
SMILES | CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCC[C@H]4CCO |
Dinaciclib (SCH 727965)是一种有效且选择性的细胞周期蛋白依赖性激酶(CDK)抑制剂,选择性抑制CDK1,CDK2,CDK5和CDK9,IC50值分别为3、1、1和4 nM。
Targets
CDK2 (Cell-free assay) | CDK5 (Cell-free assay) | CDK1 (Cell-free assay) | CDK9 (Cell-free assay) | |
1 nM | 1 nM | 3 nM | 4 nM |
In vitro (25°C) | DMSO | Warmed: 22 mg/mL (55.48 mM) | |
Water | Insoluble | ||
Ethanol | Warmed: 7 mg/mL (17.65 mM) | ||
In vivo | 2% DMSO+30% PEG 300+ddH2O | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 25.22 mL | 126.1 mL | 252.21 mL |
0.5 mM | 5.04 mL | 25.22 mL | 50.44 mL |
1 mM | 2.52 mL | 12.61 mL | 25.22 mL |
5 mM | 0.5 mL | 2.52 mL | 5.04 mL |
*The above data is based on the productmolecular weight 396.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.